Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.
Identifieur interne : 001C91 ( PubMed/Curation ); précédent : 001C90; suivant : 001C92Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.
Auteurs : Chengwu Yang [États-Unis] ; Elizabeth Garrett-Mayer ; Jay S. Schneider ; Stephen M. Gollomp ; Barbara C. TilleySource :
- Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2009.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Cognition Disorders (diagnosis), Cognition Disorders (etiology), Factor Analysis, Statistical, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuropsychological Tests, Outcome Assessment (Health Care), Parkinson Disease (complications), Parkinson Disease (diagnosis), Reproducibility of Results, Schizophrenic Psychology, Severity of Illness Index.
- MESH :
- complications : Parkinson Disease.
- diagnosis : Cognition Disorders, Parkinson Disease.
- etiology : Cognition Disorders.
- Adult, Aged, Aged, 80 and over, Factor Analysis, Statistical, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neuropsychological Tests, Outcome Assessment (Health Care), Reproducibility of Results, Schizophrenic Psychology, Severity of Illness Index.
Abstract
Adequate reliability and valid factor structure are prerequisites for appropriate use of a measure in a population. Although the Repeatable Battery for Assessment of Neuropsychological Status (RBANS) has been used to examine cognition in Parkinson's disease (PD), its reliability and factor structure have not been examined in this population. This study examined the reliability and factor structure of the RBANS in participants with de novo PD recruited for two NIH Exploratory Trials in Parkinson's Disease (NET-PD), using Cronbach's alpha and factor analysis. Confirmatory factor analysis (CFA) was implemented on the factor structure proposed in the RBANS manual, and exploratory factor analysis (EFA) was conducted to identify a valid factor structure given the proposed one was not supported. The RBANS exhibited poor reliability in participants with NET-PD. Cronbach's alpha ranged from 0.03 to 0.74 for the five domains and the full scale. CFA results indicated that the proposed factor structure in the RBANS manual was not supported in this sample. EFA identified a two-factor structure for six of the 12 RBANS items. Six items were eliminated due to low correlation with other items or severe ceiling effects. This new factor structure was validated by another CFA. The two domains have fair reliability. Cronbach's alpha ranged from 0.65 to 0.74 for the two factors in the two datasets. These results suggest that the current RBANS domain and total scores may not provide valid measurement of the neuropsychological status for patients with early PD.
DOI: 10.1002/mds.22552
PubMed: 19452561
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001C91
Links to Exploration step
pubmed:19452561Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.</title><author><name sortKey="Yang, Chengwu" sort="Yang, Chengwu" uniqKey="Yang C" first="Chengwu" last="Yang">Chengwu Yang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina</wicri:regionArea></affiliation></author><author><name sortKey="Garrett Mayer, Elizabeth" sort="Garrett Mayer, Elizabeth" uniqKey="Garrett Mayer E" first="Elizabeth" last="Garrett-Mayer">Elizabeth Garrett-Mayer</name></author><author><name sortKey="Schneider, Jay S" sort="Schneider, Jay S" uniqKey="Schneider J" first="Jay S" last="Schneider">Jay S. Schneider</name></author><author><name sortKey="Gollomp, Stephen M" sort="Gollomp, Stephen M" uniqKey="Gollomp S" first="Stephen M" last="Gollomp">Stephen M. Gollomp</name></author><author><name sortKey="Tilley, Barbara C" sort="Tilley, Barbara C" uniqKey="Tilley B" first="Barbara C" last="Tilley">Barbara C. Tilley</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="doi">10.1002/mds.22552</idno><idno type="RBID">pubmed:19452561</idno><idno type="pmid">19452561</idno><idno type="wicri:Area/PubMed/Corpus">001C91</idno><idno type="wicri:Area/PubMed/Curation">001C91</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.</title><author><name sortKey="Yang, Chengwu" sort="Yang, Chengwu" uniqKey="Yang C" first="Chengwu" last="Yang">Chengwu Yang</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina</wicri:regionArea></affiliation></author><author><name sortKey="Garrett Mayer, Elizabeth" sort="Garrett Mayer, Elizabeth" uniqKey="Garrett Mayer E" first="Elizabeth" last="Garrett-Mayer">Elizabeth Garrett-Mayer</name></author><author><name sortKey="Schneider, Jay S" sort="Schneider, Jay S" uniqKey="Schneider J" first="Jay S" last="Schneider">Jay S. Schneider</name></author><author><name sortKey="Gollomp, Stephen M" sort="Gollomp, Stephen M" uniqKey="Gollomp S" first="Stephen M" last="Gollomp">Stephen M. Gollomp</name></author><author><name sortKey="Tilley, Barbara C" sort="Tilley, Barbara C" uniqKey="Tilley B" first="Barbara C" last="Tilley">Barbara C. Tilley</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cognition Disorders (diagnosis)</term><term>Cognition Disorders (etiology)</term><term>Factor Analysis, Statistical</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neuropsychological Tests</term><term>Outcome Assessment (Health Care)</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (diagnosis)</term><term>Reproducibility of Results</term><term>Schizophrenic Psychology</term><term>Severity of Illness Index</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Factor Analysis, Statistical</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neuropsychological Tests</term><term>Outcome Assessment (Health Care)</term><term>Reproducibility of Results</term><term>Schizophrenic Psychology</term><term>Severity of Illness Index</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Adequate reliability and valid factor structure are prerequisites for appropriate use of a measure in a population. Although the Repeatable Battery for Assessment of Neuropsychological Status (RBANS) has been used to examine cognition in Parkinson's disease (PD), its reliability and factor structure have not been examined in this population. This study examined the reliability and factor structure of the RBANS in participants with de novo PD recruited for two NIH Exploratory Trials in Parkinson's Disease (NET-PD), using Cronbach's alpha and factor analysis. Confirmatory factor analysis (CFA) was implemented on the factor structure proposed in the RBANS manual, and exploratory factor analysis (EFA) was conducted to identify a valid factor structure given the proposed one was not supported. The RBANS exhibited poor reliability in participants with NET-PD. Cronbach's alpha ranged from 0.03 to 0.74 for the five domains and the full scale. CFA results indicated that the proposed factor structure in the RBANS manual was not supported in this sample. EFA identified a two-factor structure for six of the 12 RBANS items. Six items were eliminated due to low correlation with other items or severe ceiling effects. This new factor structure was validated by another CFA. The two domains have fair reliability. Cronbach's alpha ranged from 0.65 to 0.74 for the two factors in the two datasets. These results suggest that the current RBANS domain and total scores may not provide valid measurement of the neuropsychological status for patients with early PD.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">19452561</PMID><DateCreated><Year>2009</Year><Month>08</Month><Day>03</Day></DateCreated><DateCompleted><Year>2009</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2014</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>10</Issue><PubDate><Year>2009</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>Movement disorders : official journal of the Movement Disorder Society</Title><ISOAbbreviation>Mov. Disord.</ISOAbbreviation></Journal><ArticleTitle>Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.</ArticleTitle><Pagination><MedlinePgn>1453-60</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.22552</ELocationID><Abstract><AbstractText>Adequate reliability and valid factor structure are prerequisites for appropriate use of a measure in a population. Although the Repeatable Battery for Assessment of Neuropsychological Status (RBANS) has been used to examine cognition in Parkinson's disease (PD), its reliability and factor structure have not been examined in this population. This study examined the reliability and factor structure of the RBANS in participants with de novo PD recruited for two NIH Exploratory Trials in Parkinson's Disease (NET-PD), using Cronbach's alpha and factor analysis. Confirmatory factor analysis (CFA) was implemented on the factor structure proposed in the RBANS manual, and exploratory factor analysis (EFA) was conducted to identify a valid factor structure given the proposed one was not supported. The RBANS exhibited poor reliability in participants with NET-PD. Cronbach's alpha ranged from 0.03 to 0.74 for the five domains and the full scale. CFA results indicated that the proposed factor structure in the RBANS manual was not supported in this sample. EFA identified a two-factor structure for six of the 12 RBANS items. Six items were eliminated due to low correlation with other items or severe ceiling effects. This new factor structure was validated by another CFA. The two domains have fair reliability. Cronbach's alpha ranged from 0.65 to 0.74 for the two factors in the two datasets. These results suggest that the current RBANS domain and total scores may not provide valid measurement of the neuropsychological status for patients with early PD.</AbstractText><CopyrightInformation>Copyright 2009 Movement Disorder Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Chengwu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Bioinformatics, and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrett-Mayer</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Jay S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Gollomp</LastName><ForeName>Stephen M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Tilley</LastName><ForeName>Barbara C</ForeName><Initials>BC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>3P30 AG021677-02S1</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>44555</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 NS043127</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01NS043127</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01NS043128</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U10NS44415</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mov Disord</MedlineTA><NlmUniqueID>8610688</NlmUniqueID><ISSNLinking>0885-3185</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Mult Scler. 2002 Oct;8(5):382-9</RefSource><PMID Version="1">12356204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Clin Neuropsychol. 2003 Jul;18(5):509-20</RefSource><PMID Version="1">14591446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Clin Neuropsychol. 2004 Sep;19(6):825-34</RefSource><PMID Version="1">15288335</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Schizophr Res. 2004 Oct 1;70(2-3):175-86</RefSource><PMID Version="1">15329294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 1990 Oct;40(10):1529-34</RefSource><PMID Version="1">2215943</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9</RefSource><PMID Version="1">9845158</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Exp Neuropsychol. 2005 Jan;27(1):16-32</RefSource><PMID Version="1">15814440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Med. 2006 Feb;119(2):166.e7-16</RefSource><PMID Version="1">16443422</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2006 Mar 14;66(5):664-71</RefSource><PMID Version="1">16481597</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Clin Neuropsychol. 2006 Dec;20(4):702-15</RefSource><PMID Version="1">16980256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Geriatr Psychiatry. 2006 Nov;14(11):976-9</RefSource><PMID Version="1">17068320</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Neurology. 2007 Jan 2;68(1):20-8</RefSource><PMID Version="1">17200487</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Bipolar Disord. 2007 Feb-Mar;9(1-2):63-70</RefSource><PMID Version="1">17391351</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Clin Neuropsychol. 2008 Jan;23(1):63-72</RefSource><PMID Version="1">17919882</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Appl Neuropsychol. 2008;15(4):274-9</RefSource><PMID Version="1">19023744</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Clin Neuropsychol. 2007 Jan;22(1):91-8</RefSource><PMID Version="1">17141467</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D003072">Cognition Disorders</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005163">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D017063">Outcome Assessment (Health Care)</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D015203">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D012565">Schizophrenic Psychology</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">NIHMS488110</OtherID><OtherID Source="NLM">PMC3915413</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>5</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22552</ArticleId><ArticleId IdType="pubmed">19452561</ArticleId><ArticleId IdType="pmc">PMC3915413</ArticleId><ArticleId IdType="mid">NIHMS488110</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C91 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001C91 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:19452561
|texte= Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19452561" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a MovDisordV3
| This area was generated with Dilib version V0.6.23. |  |